Home
Journals
Focus
Videos
Language
English
中文简体
Sign in
All
Title
Author
Year
Keyword
Text
Search
Journals
Engineering
2
Frontiers of Medicine
7
Selected
Sort by
select
Time desc
Time asc
Export
EndNote
RefWorks
NoteExpress
BibTe
Ref Manager
ProCite
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
CTLA-4, PD-1, PD-L1, immune checkpoint blockade (ICB), metabolic reprogramming, combined tumor therapeutic strategies
Frontiers of Medicine
2023.17(5) 805-822
Application of StrucGP in medical immunology: site-specific -glycoproteomic analysis of macrophages
macrophage, glycoproteome, glycopeptides,
N
-glycan structures, PD-L1
Frontiers of Medicine
2023.17(2) 304-316
DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer: Development of Predictive Biomarkers
Chuandong Geng Timothy C. Thompson
Engineering
2022.12(5) 12-15
High-Affinity Decoy PD-1 Mutant Screened from an Epitope-Specific Cell Library
Article
Hao Liu Chunxia Qiao Naijing Hu Zhihong Wang Jing Wang Jiannan Feng Beifen Shen Yuanfang Ma Longlong Luo
Decoy PD-1, PD-L1, Mammalian cell library, Epitope-oriented
Engineering
2021.7(11) 1557-1565
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Shi-Yong Sun
mTOR,cancer therapy,resistance,GSK3,protein degradation,E3 ubiquitin ligase,PD-L1,
Frontiers of Medicine
2021.15(2) 221-231
Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy
Min Zhang Jingwen Yang Wenjing Hua Zhong Li Zenghui Xu Qijun Qian
immune checkpoint,companion diagnosis,PD-L1,tumor mutation burden,immune score,
Frontiers of Medicine
2019.13(1) 32-44
PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
Yumeng Wang Guiling Li
PD-1,PD-L1,immune checkpoint blockade antibody,immunotherapy,cervical cancer,
Frontiers of Medicine
2019.13(4) 438-450
Activation of phagocytosis by immune checkpoint blockade
Chia-Wei Li Yun-Ju Lai Jennifer L. Hsu Mien-Chie Hung
CD47,PD-1,PD-L1,immunotherapy,TAM,phagocytosis,macrophage
Frontiers of Medicine
2018.12(4) 473-480
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
Yingyan Yu
molecular classification,precision medicine,pembrolizumab,PD-1/PD-L1,MSI-H,
Frontiers of Medicine
2018.12(2) 229-235
Prev
Next
Related search
Relevant information